Kate Saylor, Ph.D.

Assistant Prof of Bioethics @GeisingerHealth. Bioethics, genetics, priority-setting. Former: @PennMEHP, @unc Public Policy PhD, @nih science policy, @ngpohsu

[Kate Saylor, Ph.D. @kwsaylor]

Here's my quote tweet about this quote tweeting experiment. @douglaspmackay and I explore the ethics of an experiment in a non-medical context-- the academic job market. Some highlights to follow. Let us know what you think!

[Kate Saylor, Ph.D. @kwsaylor]

A question for academics: what is your favorite reference manager and why? My institution supports Endnote, Mendeley and RefWorks. I've heard Mendeley lost a lot of functionality, but I am curious about how it compares to Endnote. (I've been using Zotero, but it's not an option)

[Kate Saylor, Ph.D. @kwsaylor]

If you are at UNC tomorrow, go check out this talk by Doug MacKay. I think it's going to be a lively discussion.

[UNC College of Arts and Sciences @unccollege]

Tomorrow, join the Parr Center for "Ethics Around The Table." Public policy professor Doug MacKay discusses the impact of social media promotion on the job market.

🗓️ Tues, Sept. 24
⏰ 12:30-1:30 p.m.
📍Dey Hall, Toy Lounge

https://t.co/DB3uIElXD2
@theparrcenter

[Kate Saylor, Ph.D. @kwsaylor]

@UWLaFollette @cpdurrance Congratulations! That's wonderful news.

[Kate Saylor, Ph.D. @kwsaylor]

NHGRI is hiring their next division director of genomic science-- spread the word/apply! https://t.co/7ce6cQtblJ

[Kate Saylor, Ph.D. @kwsaylor]

7. Non-medical research can benefit from the rich research ethics literature. Yet, there are issues in non-medical experiments that need more attention (e.g., bystander risks). Systematic analysis of these issues in econ and other social sciences is needed. END.

[Kate Saylor, Ph.D. @kwsaylor]

Here's my quote tweet about this quote tweeting experiment. @douglaspmackay and I explore the ethics of an experiment in a non-medical context-- the academic job market. Some highlights to follow. Let us know what you think!

[Kate Saylor, Ph.D. @kwsaylor]

6. On the other hand, the study also involved a weighted randomization process, in which candidates from underrepresented minorities had a higher chance of getting quote tweeted. This approach supports professional norms of inclusion and equity

[Kate Saylor, Ph.D. @kwsaylor]

@brootmcq @PublicPolicyUNC Thank you!

[Kate Saylor, Ph.D. @kwsaylor]

@scottlangford22 Thank you, Scott! Your kind words mean a lot to me. Onward and upward

[Center for Chronic Disease Research & Policy @ChronicDiseaseU]

May 29 at 12PM CT: @NataliaKunst of @CHEyork @UniOfYork will present "An Iterative Approach to Decision-Making in Health and Medicine: Evidence and Uncertainty Considerations at the CDRP Chronic Diseases and Medical Decision-Making Workshop -- join us on Zoom!

[Kate Saylor, Ph.D. @kwsaylor]

@dandekadt Another potential concern: It might seem like only potential benefits to participants randomized to treatment, but there is potential for direct harm for controls competing for the same jobs. Same potential harms to non-participants. The jobs are scarce, 0 sum.

[Kate Saylor, Ph.D. @kwsaylor]

@dandekadt @matthewcomey I agree that, if consent is needed at all, participants should have been informed about the randomization. Based only on these tweets, this looks like inadequate informed consent to me. If there was deception or withheld design info, that requires a strong justification.

[Kate Saylor, Ph.D. @kwsaylor]

@academic_exit Fastest? Data fabrication, plagiarism, culture of miss-aligned incentives, and a very hands-off/pro-forma committee. Done!

[Kate Saylor, Ph.D. @kwsaylor]

I love this! Great work by the postdocs and grad students, and thanks for making all the materials available. We need more of this.

[Daphne Martschenko, PhD @daphmarts]

New paper led by the fantastic @RoshniAPatel and @raungar: "Increasing equity in science requires better ethics training: A course by trainees, for trainees." This is work I feel so strongly about as having an impact.

https://t.co/fjUPBeHjUz